This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Methylphenidate-Induced Akathisia in a Patient With Multiple Sclerosis

Maria S. Almeida, MD; Prasad R. Padala, MD; Subhash Bhatia, MD

Published: December 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Methylphenidate is a short-acting psychostimulant thatis structurally and pharmacologically similar to dextroamphetamineand is primarily used in the treatment of attention-deficit/hyperactivity disorder (ADHD).1,2 Its use has also been exploredfor the treatment of apathy and for augmentation ofeffects of antidepressants.3 It acts as a dopaminergic and noradrenergicreuptake inhibitor.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 8

Quick Links: